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Abstract 
 
 
Background: Colorectal cancer mortality could be decreased with risk-appropriate cancer 
screening. We examined the efficacy of three tailored interventions compared to Usual Care 
for increasing screening adherence. 
Methods: Women (n=1196) ages 51 to 74, from primary care networks and non-adherent to 
colorectal cancer guidelines were randomized to: 1) Usual Care, 2) tailored Web intervention, 
3) tailored Phone intervention, or 4) tailored Web + Phone intervention. Average-risk women 
could select either stool test or colonoscopy, while women considered at higher than average 
risk received an intervention that supported colonoscopy. Outcome data were collected at 6 
months by self-report followed by medical record confirmation (attrition of 23%). Stage-of-
change for colorectal cancer screening (Precontemplation or Contemplation) was assessed at 
baseline and 6 months. 
Results: The Phone (41.7%, p<.0001) and combined Web+Phone (35.8%, p<.001) 
interventions significantly increased colorectal cancer screening by stool test compared to 
Usual Care (11.1%) with odds ratios ranging from 5.4 to 6.8 in models adjusted for 
covariates. Colonoscopy completion did not differ between groups, except that Phone 
significantly increased colonoscopy completion compared to usual care for participants in the 
highest tertile of self-reported fear of cancer.  
Conclusion: A tailored Phone with or without a Web component significantly increased 
colorectal cancer screening compared to Usual Care, primarily through stool testing, and 
phone significantly increased colonoscopy compared to usual care but only among those 
with the highest levels of baseline fear.   
Impact: This study supports tailored phone counseling with or without a web program for 
increasing colorectal cancer screening in average risk women.  
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Introduction 
 Despite evidence that breast and colorectal cancer screening can significantly reduce 
mortality, screening rates fall below the standards set by the Healthy People 2020 initiative (1-
3). We report colorectal cancer screening outcomes from a randomized controlled intervention 
trial supported by the National Cancer Institute and developed to increase colorectal cancer 
screening using tailored Web and Phone-based interventions. All women were nonadherent 
to colorectal cancer screening at baseline.  
     Randomized clinical studies show behavioral interventions, including mailed invitations, 
telephone counseling, navigation, and a combination of patient navigation and telephone 
support, significantly increase colorectal cancer screening compared to usual Care (4-7). 
Furthermore, tailoring to demographic and belief variables (e.g., perceived risk, perceived 
benefits, perceived barriers, self-efficacy, fatalism, and fear) increases relevance of the 
intervention messages, thereby increasing intervention effects (8-10). When comparing tailored 
messages to non-tailored approaches or to motivational interviewing, some research has found 
tailored messages significantly improve cancer-screening behaviors (11-19). Furthermore, 
studies found that that allowing average risk individuals to select either stool test or 
colonoscopy resulted in increased screening (20, 21). 
     Although tailored interventions are efficacious, most studies have not tailored on a 
comprehensive set of variables that include baseline stage of change, demographics, and belief 
variables. (22, 23). With rapid advances in technology, our ability to develop phone or web-
based messages tailored to a larger set of variables is possible. Additionally, although prior 
studies had utilized telephone counseling, at the time the present study was designed, few 
tailored web-based interventions had been tested, and most phone counseling interventions did 
not include tailored messaging. If a web-based approach were efficacious, it could potentially 
decrease cost and increase dissemination for cancer screening interventions. Finally, it was 
hypothesized that the additive effect of web plus phone had the potential to increase screening 
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beyond either individual intervention. 
     Thus, this trial used a full 2X2 factorial design to assess tailored messaging delivered by Web, Phone or 
both Web+Phone compared to Usual Care to increase completion of colorectal cancer screening. A 
secondary outcome was stage-of-change for colorectal cancer screening (intention to screen). 
Covariates included demographics, comorbidities, and baseline colorectal cancer knowledge, beliefs, 
and stage-of-change for colorectal cancer screening. Specific research questions were: 
1) Are there differences between randomized groups and usual care in adherence and stage-of-
change for colorectal cancer screening defined as: a) stool test, b) colonoscopy, c) either
screening test (stool test or colonoscopy), d) risk-appropriate screening.
Methods 
     Study design: A prospective, randomized factorial design compared the impact of three tailored 
interventions to Usual Care on colorectal cancer screening adherence and stage-of-change to 
complete colorectal cancer screening. A total of 1196 woman were randomized to four groups: 1) 
Usual Care, 2) tailored Web-based, 3) tailored Phone counseling, or 4) a Web-based + Phone 
counseling intervention. The Consort Diagram is illustrated in Figure 1. The randomization was 
performed in a Microsoft SQL database, using SQL random ordering functions, without additional 
stratification. The sample size (at least 200 in each randomized arm) was calculated to yield a power 
of 80% to detect a 15% difference between each intervention group and Usual Care on the primary 
outcome of 6 month best-estimate for any CRC screening (e.g., 200 per arm yields 86% power for 
35% vs 20%; or 92% power for 50% vs 35%; see Table 2 footnote for the actual sample size, which 
was slightly greater than 200 per arm. The study was approved by the Institutional Review Board at 
Indiana University and community sites.  This study is registered with the clinical trials identifier 
NCT03279198 https://clinicaltrials.gov/show/NCT03279198. 
     Women were interviewed at baseline and 6 months post-intervention. Medical records were 
obtained at 6 months post-intervention to verify screening and obtain a six month outcome variable, if 
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women dropped prior to 6 month data collection. Women assigned to the Web-based intervention 
group completed an interactive computer program that provided tailored messages based on their 
feedback to tailoring questions quieried throughout the program. Women assigned to the Phone 
intervention received messages from a trained interventionist and tailored to real time feedback-with 
similar to the Web program. Women assigned to the combination of Web and Phone were first 
directed to complete of the Web program followed within four weeks by a Phone counseling 
intervention. If women had not completed the Web program within four weeks of being randomized, 
research assistants called to schedule the Phone counseling but emphasized completion of the Web 
program prior to their Phone counseling appointment.  
     Eligibility and recruitment: Women were eligible if they were ages 50 to 75, nonadherent to 
colorectal cancer screening guidelines, and had access to the internet. To be considered 
nonadherent, participants had to confirm they had not completed: 1) a fecal stool test in the last 
15 months; 2) a sigmoidoscopy in the last 5 years; or 3) a colonoscopy in the last 10 years. 
Exclusion criteria included: 1) having a personal history of colorectal cancer, colorectal polyps, or 
inflammatory bowel disease, and 2) having any medical conditions that would prohibit colorectal 
cancer screening. Although all women were non adherent to colorectal cancer screening, 
approximately half of the women accrued were currently adherent to breast cancer screening and 
half non adherent to breast cancer screening.  Adherence to breast cancer screening status was 
used as a covariate.  
     A list of women ages 50 to 75 with no medical record of guideline-based screening for 
colorectal cancer or exclusionary criteria in two community-based family health care systems 
was forwarded to Indiana University’s Survey Center whose staff completed all accrual and 
data collection calls. Prior to calling women, introductory letters were mailed explaining the 
study and offering an opt-out opportunity through returning a postage-paid postcard or calling 
a toll-free number. If women did not opt out after two weeks, a call was placed to confirm 
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eligibility and explain details of the study. After confirming eligibility, women were asked if they 
would participate and verbal consent was obtained for the baseline interview which was 
completed during the initial conversation. Women were also allowed the opportunity to 
complete the baseline survey via web.  After verbal or web consent, participants were mailed 
a Health Insurance Portability and Accountability Act (HIPAA) authorization form for release of 
medical record data and a written informed consent which was mailed back with a postage 
paid envelop. Data were collected at three times-baseline, two weeks after intervention 
(process data) and six months after intervention. Participants received a $20.00 gift certificate 
at each data collection time point. 
     Outcomes of interest: Outcomes were completion of colorectal cancer screening by stool test, 
colonoscopy, either screening test, or a risk-appropriate screening test. Risk-appropriate CRC 
screening was defined as completion of the appropriate test based on the level of risk 
conferred by family history. For participants who had more than one first- degree relative who 
was diagnosed with CRC or a first-degree relative diagnosed younger than age 60, 
colonoscopy is the most appropriate screening test (24). Therefore, we examined whether 
women had completed the appropriate test based on their CRC risk (family history). A total of 
275 (23%) were lost to follow-up. The Web group had the highest attrition (27%) and the Phone 
group had the lowest (18%). For analyses, we used a best estimate outcome data set which 
combined both self-report and medical record data. We counted the screening positive if either 
self-report or medical record data indicated a screening test. This best-estimate data set allowed 
us to include women who did not have six-month self-report but had medical record data or 
conversely allowed use of self-report data, if medical records data were not available. Although 
kappa coefficients showed adequate agreement (.76 for stool test and .85 for colonoscopy) the 
best estimate dataset served to decrease potential bias due to missing data in either interview or 
medical record information.  
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     Measures: Demographic information, family history, and cancer screening history were 
assessed using standard questions. Belief scales of perceived risk of colorectal cancer, 
perceived benefits and barriers to colorectal cancer screening, self-efficacy, fatalism, and fear 
were measured by scales found to be valid and reliable in past research (25-27). Intention to 
screen for colorectal cancer and actual screening were assessed by questions successfully 
used in past research (28). 
Interventions 
     Web only Intervention: A tailored health behavior change intervention was guided by the 
Health Belief Model, the Transtheoretical Model, and the Likelihood Persuasion Behavioral 
Theory (29-32). Tailoring focused on key demographic variables (e.g., age, race) and belief 
variables (mediators) that were theoretically linked to screening behavior in addition to 
preferred colorectal cancer screening test (33-35). An algorithm embedded in the program 
directed women at higher than average risk to an intervention that encouraged colonoscopy while 
women at average risk were allowed to select either stool test or colonoscopy followed by a 
program consistent with their preferred test.     
     The tailored Web program was developed such that a woman’s demographic and belief 
responses (queried throughout the program) triggered an algorithm which selected and 
delivered messages tailored to each woman’s response. Constructs used for tailoring included 
age, race, family history of colon cancer, knowledge and beliefs about colon cancer and 
colorectal cancer screening. Messages were developed and refined from previous research 
using similar tailoring (22). For example, if a woman did not perceive a personal risk for 
colorectal cancer or benefits of screening, messages were delivered to reinforce the fact that 
colorectal cancer can happen to anyone and that screening identifies cancer early when 
treatment is most successful. Women were able to identify up to three personal barriers and 
for each barrier identified, a message was delivered suggesting ways to overcome the barrier. 
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The Web program included graphs, text, videos and animation to reinforce verbal messaging.  
Further information about development of the tailored program is provided in Supplemental 
Data Table 1. 
     Phone only Intervention: A computer program was used to structure the content and flow of the 
telephone counseling session. The trained interventionists queried women throughout the program to 
tailor messaging. Messaging was delivered in a conversational way to increase engagement and 
interest of participants. The computer interface provided structure for discussing content consistent with 
the message flow in the Web-based program. Telephone interventionists were trained during an intensive 
2-day session with an opportunity for role playing. All telephone interventions were audio recorded with
the consent of the participant. For people at average risk, the interventionist ask about their preferred 
tests and if a woman stated stool test, it was mailed to their home. If the woman were at high risk or 
preferred colonoscopy, a number to schedule the colonoscopy was provided. The mean time for the 
Phone intervention was 19 minutes. 
     Treatment fidelity was enhanced by: 1) extensive training of interventionists that included 
practice and return demonstration of skills; 2) implementation of a process evaluation for all 
participants to evaluate their receipt of, and satisfaction with, the interventions; and 3) monitoring of 
a random selection of 101 (17%) recorded telephone interventions with performance feedback as 
needed (36). Evaluators used a checklist to evaluate each call which included ratings of the degree 
of completeness and quality of the information delivered by the interventionist.  
     Web + Phone Intervention:  Women randomized to the combined Web and Phone intervention 
completed the Web program followed within four weeks by Phone counseling. The time for the 
phone intervention in this arm did not differ significantly from the time used in the phone 
intervention alone (19 minutes).  
     Usual Care: Women randomized to Usual Care did not receive an intervention, but 
depending on location of the family practice site, enrolled women may have received a postcard 
reminder for cancer screenings from their primary care provider. 
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     Study Endpoints and Analytical Strategy: The primary study endpoint for analyses was 
colorectal cancer screening test completion at six months post-intervention. Of the 1,196 
women who completed baseline interviews, 921 had screening data from either six-month 
self-report, medical record, or both and were included in analyses. An intent to treat analyses 
(i.e., all participants are analyzed according to randomized group, regardless of adherence 
to intervention) was completed. However, although we attempted an intent to treat design 
(collect all data on consented participants even if they dropped out before follow up 
interview), we were not able to obtain outcome data (medical record or self-report) on all 
participants (36,37). 
     Four colorectal cancer screening outcomes were created based on best-estimate data from 
medical record or self-report. Additionally, we modeled stage-of-change for screening with self-
report data. (Table 2, Model 2). Women were considered to be in Precontemplation if they did not 
intend to have colorectal cancer screening in the next six months and in Contemplation if they 
intended to have colorectal screening in the next six months. Action was defined as being 
adherent to colorectal cancer screening guidelines and this stage could apply only to women who 
were adherent at six months. Thus, after intervention, women could move from: 1) 
Precontemplation to Contemplation; 2) Contemplation to Action (1 step forward); or 3) 
Precontemplation to Action (2 steps forward). 
      Multinomial logistic regression models were used to model 6-month stage-of-change by 
simultaneously estimating odds ratios for women in Action or Contemplation at six months while 
adjusting for the stage at baseline (either Precontemplation of Contemplation). In binary and 
multinomial logistic regression models, randomized group assignment and baseline covariates 
were entered as the independent variables. Covariates entered were either theoretically 
justified or differed between randomized groups at the 0.10 alpha level (see covariates listed in 
Table 2 footnote). Wald chi-square tests, adjusted odds ratios, and 95% confidence intervals 
were reported.  Interactions between the intervention and baseline covariates were tested for 
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potential moderating effects, using a conservative alpha of 0.01. 
Results 
     A total of 1,716 woman were eligible for the study. Of these, 520 refused, resulting in a 
participation rate of 70%. Of the 1,196 women enrolled, 921 had 6-month follow up data (See Figure 
1). Demographic characteristics of the women did not differ by group. (Table1). The mean age was 
58.9 (SD=6.2). A total of 24.3% of women reported a high school education or less, 42% reported 
one or more years post high school and 30.2% reported a 4-year college degree or higher. The 
predominant race was Caucasian (86.3%), while 10.4% of participants were African-American. A 
total of 60% were married or living with a partner. Income was distributed as $30,000 
 or less (31.2 %), $30,001 to $75,000 (41.2%), $75,001 or above (27.6%). 
     Univariate analyses of colorectal cancer screening outcomes is illustrated in Figure 2. 
Percentages of women adherent at six months to any colorectal cancer screening test 
(Web=22.7%, Phone=52.5%, Web+Phone=44.4%, Usual Care=24.6%) were very similar to 
the percentages adherent to risk-appropriate colorectal cancer screening (Web=21.8%, 
Phone=52.3%, Web+Phone=43.7%, Usual Care=24.6%). Colonoscopy rates did not differ by 
group. 
     Logistic regression was used to compare interventions groups to Usual Care on each 6-
month screening outcome while controlling for important covariates (See Table 2 and footnote). 
Model 1 in Table 2 identifies the p-values and adjusted odds ratios for colorectal cancer 
screening at 6 months by intervention group. Because none of the theoretically identified 
covariates had significant odds ratios after adjusting for each other, we display only the group 
differences in tables. Screening adherence at six months for any colorectal cancer screening 
test or for risk-appropriate colorectal cancer screening was significantly higher for women 
in the Phone and Phone+Web intervention groups (p<0.0001) compared to the Usual Care. 
Completion of a stool test was similar across groups (Web=11.9%, Phone=41.7%. Web + 
on June 19, 2019. © 2018 American Association for Cancer Research. cebp.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on September 4, 2018; DOI: 10.1158/1055-9965.EPI-18-0180 
12  
Phone=35.8%, and Usual Care=11/1%).  Adherence for colonoscopy was low (Web, 11.8%, 
Phone, 17.2%, Web+Phone 15.0% and Usual Care 15.3%)-with no significant differences 
across groups.  
     The four randomized groups were compared on stage-of-change to screen. In Model 2 
(Table 2), the odds of being in Contemplation or Action (versus pre-contemplation) at 6 months 
are reported, adjusted for baseline stage and covariates. Demographic and experiential 
variables entered into the equation were not significant. Table 2 provides data to interpret 
efficacy to move or retain participants to Contemplation or to move participants to Action, 
adjusted for baseline stage. All three intervention arms (including Web only) were significantly 
better than Usual Care in increasing the odds for being in Contemplation vs Precontemplation 
at 6 months for any colorectal cancer screening test (Web p<0.0140, Phone p<0.0057, 
Web+Phone p<0.0032), for risk-appropriate colorectal cancer screening (Web p=0.0179, 
Phone p<0.0270, Web+Phone p<0.0053), and for stool test (Web p<0.0100, Phone p<0.0281, 
Web +Phone p=0.0017).  Compared to Usual Care, none of the interventions had a significant 
effect on 6-month stage-of-change for colonoscopy. 
     When considering efficacy to move participants to Action from Precontemplation at 6 months 
for any colorectal cancer screening test the Web was marginally significant (p<0.0537), while 
the  Phone (p<0.00001), Web+Phone (p<0.0001) ,were very significant compared to Usual 
Care.  For risk-appropriate colorectal cancer screening, Phone (p<0.00001) and 
Web+Phone (p<0.0001) interventions were significantly different than Usual Care in moving 
women to from Precontemplation to Action. For stool tests, the Phone (p<0.0001) and 
Web+Phone (p<0.0001) interventions were significantly better than Usual Care for moving 
women from Precontemplation to Action. Intervention arms were not different from Usual Care 
in completion of colonoscopy. 
     Interaction tests revealed only one significant interaction at 0.01 alpha between intervention 
effects and baseline covariates (p = 0.0008).  Specifically, post-hoc simple effects showed that 
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among participants in the highest tertile of baseline fear scores (n = 253), Phone was 
significantly more effective than usual care at moving participants to obtain a colonoscopy 
(odds ratio = 16.39 [2.84, 94.79], p = .002).  
Discussion 
     Results demonstrate the significant impact of Phone counseling to promote colorectal 
screening. Importantly, the interventions that included Phone included the proactive offer of a 
mailed stool kit. It is probable that a stool test mailed to their home was the major factor 
producing the large effect sizes found for Phone and Phone+Web in this study, consistent with 
other researchers who found that mailing stool test kits increased colorectal cancer screening 
(7).  In particular, Singal found that mailing stool test kits to primary care patients resulted in 
participation rates of close to 59% (38). 
     Another factor that may have increased the effects found in this study was allowing average 
risk women (95%) to select preferred tests. Myers studied 764 African Americans ages 50 to 75 
and found that in an intervention, which included a navigation component, persons who 
expressed a preference for stool testing were much more likely to obtain a stool test than a 
colonoscopy (41.1% vs. 7.1%) (39).  The comparison group, with no personal contact, showed 
a much smaller advantage for stool testing among persons who expressed a preference (12.1% 
vs. 7.6%), even though a stool kit had been mailed to them. The personal contact with an 
interventionist  may be an important factor (39).   
     We cannot conclude that tailoring played a role in the large effect found with our Phone 
intervention groups. Without a non-tailored phone intervention arm, we do not know if the 
tailoring used for phone messaging increased stool testing beyond what a non-tailored phone 
call and mailing stool kits would have accomplished. The fact that the tailored Web-based 
program did not increase screening and the tailored Phone intervention with mailed stool kits 
did, suggests that tailoring did not add to the effectiveness of the Phone intervention, although, 
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it is possible that the interaction of tailoring and personal contact by phone added to the effect 
size we found. Additionally, we have no way of knowing whether mailing  a stool kit without a 
tailored web or phone intervention would have been more effective than usual care. 
     The tailored Web-based intervention did not increase stool testing compared to Usual Care, a 
finding supported by other studies using a web-based approach. In a similar attempt to use a 
tailored interactive computer intervention to promote colorectal cancer screening, Vernon did not 
find a significant difference in randomized groups comparing a tailored interactive computer 
program, an informational web program or a survey only group for improving colorectal cancer 
screening (40). Our decision to use a Web-based approach as one media for delivery reflected the 
growing penetration of households that now have high speed internet- approximately 75% (46) and 
the hope that this less expensive intervention could increase screening. The combination of Web 
plus Phone, although significantly different from Usual Care, produced slightly lower effect sizes 
than the Phone alone, suggesting that in the presence of Phone outreach, a web-based 
intervention did not add to the effect.     
     Rates of colonoscopy screening were not significantly different for any intervention group 
compared to Usual Care, except when considering the moderating effect of fear. In retrospect, this 
outcome is understandable. Women at average risk were allowed to select a preferred test and if 
screening by stool test was the preferred modality, colonoscopy was not promoted, and the 
intervention focused on stool testing. Furthermore, 95% of women in our sample were at 
average risk and of those assigned to intervention groups, (Usual Care didn’t select preferred 
test) 63% stated preference for stool test, 37% stated preference for colonoscopy, and 1% did 
not state preference. Given the overwhelming preference for stool testing, it is probable that the 
intervention forestalled women from thinking about colonoscopy. However, research suggests 
that for women at higher than average risk, phone interventions have significantly increased 
colonoscopy compared to usual care (41-43). Kinney (2014) tested a telehealth intervention with 
relatives of colorectal patients using tailored content via phone outreach compared to a mailed 
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educational brochure and found the telehealth intervention resulted in 35.4% of those in the 
telehealth vs only 15.7% in the mailed brochure completed colonoscopy (43).  Additionally, in a 
sample of high-risk individuals with a family history of colorectal neoplasia, a tailored nurse led 
intervention resulted in a significant uptake of colonoscopy compared to control (p=.0027) (44). 
     Demographic and belief variables were tested for moderation and the only significant (alpha 
0.10) interaction was between the phone only group and higher levels of fear. Among those with 
the highest levels of baseline fear of cancer, the Phone intervention group had significantly higher 
rates of obtaining colonoscopy that Usual Care. This suggests a future opportunity to move high-
risk persons to obtain colonoscopy if they report higher levels of fear of cancer.   
     Although stages of change have been used in a range of behavioral interventions, its use has 
been limited for studies assessing colorectal cancer screening. We tested the ability of any 
intervention group compared to Usual Care to advance stage movement for colon cancer 
screening.  All three interventions, including the Web, were successful in promoting forward stage 
movement from Precontemplation to Contemplation. Additionally, the Web-based intervention, 
like interventions with phone counseling was marginally significant in moving women in 
Precontemplation at baseline to Action. A research study that also used stage movement in 
analyses found an intervention effect for forward stage movement, although no overall 
increase in actual screening was found (40).  Our Web-based intervention included compelling 
stories from other women about the necessity to screen, an animation of how cancer develops 
and a visual description of screening tests; perhaps these elements were most important for 
women who were not considering screening at baseline, allowing the Web-based intervention 
to increase screening for women at the 6-month follow-up.  
Limitations 
     As with all studies, results of this RCT should be interpreted within the context of the study’s 
limitations. Women comprised a volunteer sample and included only 70% of those invited. 
Additionally, women were primarily Caucasian and patients of family practice clinics, already engaged 
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with the medical care system. Results could differ for persons without a health care home or for 
women of color or Hispanic origin. Furthermore, we were not able to follow women to determine 
intervention effectiveness for having subsequent annual stool testing. We implemented an intent-to 
treat design, however, because outcome data were not available on all consented participants, the 
number analyzed was smaller than the number consented. Finally, additional research is needed to 
determine the most effective intervention that will support colonoscopy, especially for those women at 
higher than average risk who require a colonoscopy.   
Conclusion  
     The tailored Phone interventions with or without a Web-based program, significantly increased 
screening for all participants by stool tests, with the large effect sizes probably due to outreach by 
Phone and proactive mailing of preferred test (stool kit). The tailored web-based intervention 
increased screening only in the subgroup of women in Precontemplation at baseline although this 
finding was only marginally significant. The interventions tested in this study did not increase 
screening by colonoscopy-with the exception of those with high fear at baseline- possibly because 
95% of women were at average risk and were allowed to select their preferred screening test which 
was most often stool test instead of colonoscopy.  
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Table 1. Baseline Characteristics by Randomized Group 
Baseline 
Characteristics 
Number (%) or 
Mean (SD) 
Total 
Sample 
(n=1196) 
Web 
(n=303) 
Phone 
(n=296) 
Web + 
Phone 
(n=292) 
Usual 
Care 
(n=305) 
p- 
value 
Doctor or HCP ever 
suggested you do a 
stool test? n(%) 
responding yes 
458 (38.3) 120 (39.6) 119 (40.2) 108 (37.0) 111 (36.5) 0.7304 
Doctor ever 
recommended that 
you have a 
colonoscopy? n(%) 
responding yes 
785 (65.8) 194 (64.2) 192 (65.1) 201 (68.8) 198 (65.1) 0.6480 
Baseline adherence 
to breast cancer 
screening 
504 (42.1) 123 (40.6) 128 (43.2) 125 (42.8) 128 (42.0) 0.9185 
Baseline Colorectal Cancer Screening Stage, n(%) in Contemplation at baseline; 
(n, % in Precontemplation can be calculated as 100 - % shown below) 
Stool test at home 173 (14.5) 43 (14.2) 44 (14.9) 41 (14.0) 45 (14.8) 0.9894 
Colonoscopy 291 (24.3) 79 (26.1) 66 (22.3) 76 (26.0) 70 (22.9) 0.5858 
Any Colorectal  cancer 
Screening 
410 (34.3) 107 (35.3) 98 (33.1) 104 (35.6) 101 (33.1) 0.8639 
Risk-appropriate 
Colorectal cancer 
screening 
404 (33.8) 106 (35.0) 98 (33.2) 101 (34.6) 99 (32.5) 0.7062 
Age, mean (SD) 58.9 (6.2) 59.3 (6.4) 58.7 (6.0) 58.6 (5.9) 58.9 (6.3) 0.5727 
Highest education 0.5279 
High school 
graduate or less 
332 (27.8) 79 (26.1) 85 (28.9) 90 (30.8) 78 (25.7) 
Some college 501 (42.0) 137 (45.2) 120 (40.8) 121 (41.4) 123 (40.5) 
4 year college 
graduate to 
graduate 
degree 
360 (30.2) 87 (28.7) 89 (30.3) 81 (27.7) 103 (33.9) 
Race 0.0363 
Black or African 
American 
124 (10.4) 40 (13.2) 22 (7.4) 36 (12.3) 26 (8.5) 
White or 
Caucasian 
1032 (86.3) 255 (84.2) 269 (90.9) 243 (83.2) 265 (86.9) 
Asian, Pacific 
Islander, or Other 
40 (3.4) 8 (2.6) 5 (1.7) 13 (4.5) 14 (4.6) 
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 Married or living with 
a partner 
719 (60.4) 182 (60.1) 188 (64.0) 171 (58.8) 178 (58.8) 0.4493 
Total combined 
yearly household 
income before taxes 
     0.6973 
$30,000 or less 359 (31.2) 99 (33.9) 82 (28.8) 95 (33.3) 83 (28.6)  
$30,001 - $75,000 474 (41.2) 114 (39.0) 124 (43.5) 110 (38.6) 126 (43.5)  
$75,001 or above 319 (27.6) 79 (27.1) 79 (27.7) 80 (28.1) 81 (27.9)  
In the past year, how 
many times have you 
seen your doctor or 
other HCP? (not 
counting dentist or 
eye doctor) 
      
3 or more times, 
n (%) 
573 (48.3) 167 (55.5) 130 (44.1) 144 (49.5) 132 (44.2) 0.0144 
Body Mass Index 
(BMI) 
     0.6359 
Underweight / 
Normal 
287 (25.0) 70 (24.0) 74 (26.2) 72 (25.9) 71 (24.1)  
Overweight 324 (28.2) 86 (29.5) 82 (29.0) 66 (23.7) 90 (30.5)  
Obese 537 (46.8) 136 (46.6) 127 (44.9) 140 (50.4) 134 (45.4)  
Total number of self- 
reported health 
problems, mean 
(SD) 
1.8 (1.7) 2.1 (1.8) 1.7 (1.7) 1.8 (1.6) 1.7 (1.6) 0.0190 
Does depression 
limit your activities? 
n (%) yes, 
99 (8.5) 27 (9.1) 17 (6.0) 37 (12.8) 18 (6.0) 0.0084 
Perceived age- 
adjusted risk for 
colon cancer, n (%) 
     0.6297 
About the same or 
not sure 
873 (73.0) 216 (71.3) 212 (71.6) 225 (77.3) 220 (72.1)  
Higher risk 82 (6.9) 22 (7.3) 19 (6.4) 17 (5.8) 24 (7.9)  
Lower risk 240 (20.1) 65 (21.4) 65 (22.0) 49 (16.8) 61 (20.0)  
Cancer and Cancer 
Screening Beliefs 
      
Fatalism 20.5 (6.9) 20.4 (6.4) 20.9 (7.2) 20.6 (6.8) 20.1 (7.0) 0.6159 
Fear 23.0 (7.5) 23.1 (7.5) 23.4 (7.6) 22.9 (7.5) 22.4 (7.3) 0.4497 
Susceptibility to 
colon cancer 
6.8 (2.2) 6.8 (2.2) 6.8 (2.2) 6.8 (2.3) 6.8 (2.2) 0.9895 
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Benefits of 
colorectal 
cancer 
screening 
18.1 (3.1) 18.1 (3.1) 18.0 (3.3) 18.0 (3.0) 18.1 (3.1) 0.9260 
Barriers to Stool 
Test 
20.1 (5.0) 19.9 (5.3) 20.4 (5.0) 20.1 (5.1) 19.9 (4.6) 0.5577 
Barriers to 
colonoscopy 
36.1 (8.7) 36.0 (8.8) 36.6 (9.0) 36.3 (8.9) 35.3 (8.0) 0.2744 
Self-efficacy for 
Stool Test 
28.4 (4.8) 28.4 (4.8) 28.7 (4.5) 28.2 (5.3) 28.4 (4.7) 0.5341 
Self-efficacy for 
colonoscopy 
36.9 (7.2) 36.7 (7.5) 36.7 (7.2) 36.9 (7.3) 37.3 (6.7) 0.7387 
Knowledge for 
colonoscopy 
5.3 (1.9) 5.2 (1.9) 5.3 (1.9) 5.2 (2.0) 5.3 (1.9) 0.8782 
Note. For continuous variables and ordinal income, the two-sided independent-groups t-
test was used unless parametric assumptions were violated in which case the two-sided 
Kruskal-Wallis test was used. For categorical variables, the chi-square test was used. 
HCP = health care provider. COLORECTAL CANCER = colorectal cancer 
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Table 2. Logistic Regression (LR) Models of 6 Month (T3) Colorectal Cancer Outcomes 
 
 
 
Outcomes & 
Randomized Groups 
Best-Estimate Data (Medical 
Record and Self-Report) 
 
Self-Report Data (Stage) 
 
Model 1 (Binary LR Model) 
T3 Screen (yes/no) 
Model 2 (Generalized LR Model; 
reference category = T3 Precontemplation) 
T3 Contemplation T3 Action
Adjusted OR p-value Adjusted OR p- 
value 
Adjusted OR p-
value 
Any Colorectal Cancer 
screening test 
Web only 1.01 (0.63, 1.62) .9626 1.97 (1.14, 3.40) .0152 1.81 (0.99, 3.30) .0537
Phone only 4.00 (2.60, 6.16) <.0001 2.37 (1.28, 4.39) .0058 7.94 (4.33, 14.56) <.0001
Web + Phone 2.69 (1.73, 4.18) <.0001 2.52 (1.33, 4.77) .0045 6.68 (3.56, 12.54) <.0001
Risk-appropriate 
colorectal cancer test 
Web only 0.94 (0.59, 1.51) .7982 1.92 (1.11, 3.32) .0195 1.62 (0.89, 2.96) .1163
Phone only 4.00 (2.60, 6.17) <.0001 1.99 (1.08, 3.67) .0277 7.07 (3.89, 12.85) <.0001
Web + Phone 2.59 (1.67, 4.03) <.0001 2.37 (1.26, 4.48) .0076 6.08 (3.26, 11.34) <.0001
Stool test 
Web only 1.20 (0.64, 2.24) .5772 2.07 (1.17, 3.67) .0126 1.78 (0.86, 3.68) .1208
Phone only 6.80 (3.98, 11.60) <.0001 1.93 (1.04, 3.57) .0364 9.81 (5.21, 18.48) <.0001
Web + Phone 5.37 (3.11, 9.29) <.0001 2.86 (1.50, 5.45) .0014 12.14 (6.26, 23.57) <.0001
Colonoscopy 
Web only 0.70 (0.37, 1.33) .2794 1.02 (0.57, 1.80) .9516 0.96 (0.46, 1.97) .9005
Phone only 1.39 (0.77, 2.52) .2717 0.64 (0.35, 1.14) .1285 1.38 (0.70, 2.70) .3534
Web + Phone 0.88 (0.48, 1.61) .6750 0.83 (0.46, 1.49) .5275 0.84 (0.41, 1.72) .6274
*Models adjusted for baseline characteristics including age, race (African American vs Other), education, income, marital status, BMI, 
whether depression limits patient’s activities (yes/no), family history of 1 or more blood relatives with colon cancer (yes/no), perceived risk, 
doctor recommendation (yes/no), number of past-year primary care visits excluding eye care and dentistry (>=3), number of self- reported 
health problems, baseline adherence to mammography screening (yes/no), baseline stage of change for colorectal cancer  screening, 
knowledge, susceptibility, benefits, fear, fatalism, self-efficacy, and barriers. Self-efficacy and barriers specific for colonoscopy or stool test 
were used in colonoscopy and stool test models, respectively. Sample sizes for Models 1 and 2, respectively, were: any colorectal cancer 
(843, 683), risk appropriate colorectal cancer (842, 681), stool test (836, 642), and colonoscopy (835, 643). 
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